Cancer diagnostics developer Syantra said Wednesday that it has raised C$4.9 million (US$3.6 million) in a Series A-1 financing round.
PulseMedica Raises $12 Million CAD to Advance Eye Floater Imaging and Treatment Technology
Entos Pharmaceuticals Receives Approval from Health Canada to Begin Clinical Trial for COVID-19 Vaccine Booster
Nanostics Prostate Cancer Screening Test, ClarityDX Prostate®, becomes accessible to men in British Columbia, Saskatchewan, and Ontario
SciencePak™ partners with Alexander Chemical L.P., to produce and distribute a range of chemical and life sciences products and services.
Discover Why Health Professionals Trust NanoSALV Catalytic from NanoTess – a Novel, Cost-Effective Canadian Wound Care Technology
CAMS Exclusive Summer Sale. 15% off services from May to July for BioAlberta members
Nanostics and AHS collaborate to develop new diagnostic tools for urological diseases
FREDsense Launches Advanced Rapid Testing PFAS Analytical Services
Local AI non-profit organization to receive grant from Google Canada.
